Orvatez (Atorvastatin Calcium, Ezetimibe)

Atorvastatin calcium, the active ingredient in Orvatez, is a HMG‑CoA reductase inhibitor presented as a tablet for oral use. It lowers elevated cholesterol and triglyceride levels in adults at risk for cardiovascular disease. GNH USA supplies Orvatez as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Orvatez as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Orvatez is used primarily by the lipid‑management pathway to reduce cardiovascular risk.

- Primary hyper‑hyper‑hyper  : Reduction of LDL cholesterol and total cholesterol levels. - Heter t        : Improvement of                     … -    …  …  ... … … ....  …  ... ... …  … … """"  "  " "  " … … … " … … " " … " … …